
|Articles|March 1, 2005
- Volume 0 0
Combo Treatment Provides Relief
Advertisement
Articles in this issue
almost 21 years ago
Heart Patients Get More Appropriate Rx Treatment from Cardiologistsalmost 21 years ago
Surgeon General Report Blasts Rx Drug Importing Practicesalmost 21 years ago
Mevacor a Pharmacist-Only OTC? No Way, Advisory Group Tells FDAalmost 21 years ago
Expo Focuses on Caregiver Needsalmost 21 years ago
Early-Month Rx Fatalities Linked to Overworked Pharmacistsalmost 21 years ago
Feds Report Rx Expenditures Rose More Slowly in 2004almost 21 years ago
Rx.com Offers Alternative to PBM Mail Orderalmost 21 years ago
Americans Rate US Health Care as Pooralmost 21 years ago
Pharmacy Security Combo Pack Now Availablealmost 21 years ago
IOM Advocates Tougher Supplement StandardsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD
4
Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars
5











































































































































































































